3Satya SM. Stability of revex, nalmefene hydrochloride injection, in injectable solutions [J]. J Pharm Biomed Anal, 1996, 15 (2) : 221-226.
4PERT CB, KUHARM J, SNYDER SH. Opiate receptor: autoradiographic localization in rat brain [J]. Proc Natl Acad Sci USA, 1976, 73(10): 3729-3733.
5MARTIN WR. Muhiple opioid receptors: a little about their history and some implications related to evolution [J]. Life Sci, 1981, 28(14):1547-1554.
6DIXON R, HOWES J, GENTILE J, et al. Nalmefene: intravenous safety and kinetics of a new opioid antagonists [J]. Clin Pharmacol Ther,1986, 39(1): 49-53.
7HANG CS, IMAI N, STONE CK, et al. The role of endogenous opioids in congestive heart failure: effects of nalmefene on systemic and regional hemodynamics in dog[J]. Circulation, 1987, 75(2): 443-451.
8LUTSEP HL, ELARK WM. Neuroprotection in acute ischemic stroke: current status and future potential [J]. Drugs,1999, 1(1):3-8.
9WALKER BM, KOOB GF. Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence[J].Neuropsychopharmacyology,2007,2:156-157.
10ACETO MD, HARRIS LS, MAY EL. Dependence studies of new compounds in the rhesus monkey, rat, and mouse (1985)[J]. NIDA Res Monogr, 1986, 67:399-452.
